SNN / MicroCap Review Magazine Summer 2020
The Global Quest for A Vaccine Drives Dyadic’s C1 Adoption

Proactive Investors, June 10, 2020
Dyadic and Frederick National Laboratory to develop C1 cell lines for coronavirus vaccine candidates

Horizon, the EU Research & Innovation Magazine, April 7, 2020
Studying animal coronavirus defences is opening route to human treatments

Innovative Medicines Initiative, March 30, 2020
ZAPI is laying the groundwork for the response to zoonotic disease outbreaks like COVID-19

Animal Pharm Agribusiness, January 21, 2020
Quicker, cheaper, better is Dyadic motto